Aspira Women's Health Inc.
AWH
$0.082
-$0.0117-12.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.28% | 1.80% | -2.73% | -7.04% | -1.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.28% | 1.80% | -2.73% | -7.04% | -1.07% |
| Cost of Revenue | -5.60% | -0.88% | 6.48% | -16.90% | -0.22% |
| Gross Profit | 22.15% | 3.67% | -8.32% | 2.36% | -1.69% |
| SG&A Expenses | 2.91% | -5.53% | -6.12% | -18.89% | -20.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.74% | -5.24% | 0.06% | -20.16% | -13.51% |
| Operating Income | 17.03% | 9.04% | -1.67% | 25.00% | 18.78% |
| Income Before Tax | 55.07% | 24.63% | -52.35% | 29.63% | 32.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 55.07% | 24.63% | -52.35% | 29.63% | 32.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.07% | 24.63% | -52.35% | 29.63% | 32.72% |
| EBIT | 17.03% | 9.04% | -1.67% | 25.00% | 18.78% |
| EBITDA | 16.62% | 8.71% | -2.30% | 24.62% | 18.40% |
| EPS Basic | 72.04% | 52.18% | -2.25% | 50.61% | 46.35% |
| Normalized Basic EPS | 42.75% | 52.18% | 28.61% | 50.63% | 35.98% |
| EPS Diluted | 72.04% | 52.18% | -2.25% | 50.61% | 46.53% |
| Normalized Diluted EPS | 42.75% | 52.18% | 28.61% | 50.63% | 35.98% |
| Average Basic Shares Outstanding | 60.60% | 57.58% | 49.03% | 42.50% | 25.40% |
| Average Diluted Shares Outstanding | 60.60% | 57.58% | 49.03% | 42.50% | 25.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |